XOMD’s entry adds a cosmetic serum with a research presentation that needs to be read at the routine level. The reviewed product is Intoxicate, while the manufacturer’s study account concerns a three-part system. A brand summary should keep that difference visible before a reader follows the standalone serum offer.
We checked the official product, clinical-results and refund pages on October 14, 2026. The Midlife Skin Edit did not purchase or use any of the products. Our profile introduces the evidence and transaction boundaries developed in the longer review, without a clinical score or a personal-use testimonial.
The published formula and the study answer different questions
The ingredient declaration does not list estriol, estradiol or oxytocin. This is a label observation rather than a chemical assay. The Intoxicate article explains why technology language cannot substitute for a declared hormone ingredient. [1]
XOMD’s account describes an eight-week controlled study of the complete three-product regimen. We do not isolate a serum effect from that design or treat animated webpage counters as clinical data. Full study appraisal and individual outcome predictions are outside the evidence established by this brand profile. [2]
An individual bottle has a different purchase total
The serum was displayed at $188, with a $370 bundle versus $391 for the displayed cleanser, serum and moisturizer prices added together. Those amounts describe the offers, not a measured difference in clinical value. A selected order still needs its charges and package contents confirmed. [1]
The direct return route describes a thirty-day request period from receipt with authorization and possible fees. Subscription and TikTok purchases involve separate conditions. We did not evaluate support response, delivery or reimbursement, so none is presented as a tested advantage. [3]
The audience does not make one routine necessary
AAD’s new-product guidance offers general context for considering skincare, without endorsing XOMD or settling compatibility with existing treatment. A concern about dryness can lead to a different discussion from a cosmetic firmness objective; the midlife audience label does not erase that distinction. [4]
CoreAge Rx’s first position is a sponsored feature. XOMD’s inclusion is an editorial comparison of an identifiable product and its limitations. The directory does not turn either placement or the presence of a study link into a claim that one preparation is best for everyone.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- XOMD Intoxicate Serum - Ignite the Confidence that AttractsOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Clinical Study Results – XOMDOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Refund policy – XOMDOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- AAD: testing skincare productsGeneral cosmetic guidance rechecked November 14, 2026; this does not replace prescription instructions. · Checked November 14, 2026